JP2011510974A - ＨＭＧ−ＣｏＡ還元酵素阻害剤の調節放出製剤 - Google Patents

ＨＭＧ−ＣｏＡ還元酵素阻害剤の調節放出製剤 Download PDF

Info

Publication number
JP2011510974A
JP2011510974A JP2010544844A JP2010544844A JP2011510974A JP 2011510974 A JP2011510974 A JP 2011510974A JP 2010544844 A JP2010544844 A JP 2010544844A JP 2010544844 A JP2010544844 A JP 2010544844A JP 2011510974 A JP2011510974 A JP 2011510974A
Authority
JP
Japan
Prior art keywords
rosuvastatin
pharmaceutically acceptable
release
formulation
release pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010544844A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011510974A5 (https=
Inventor
クルカルニ，シータル
ダス，スリルパ
デシュムク，アシシュ，アショクラオ
ダラル，サティッシュ，クマール
クルカルニ，シリシュクマール
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lupin Ltd
Original Assignee
Lupin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lupin Ltd filed Critical Lupin Ltd
Publication of JP2011510974A publication Critical patent/JP2011510974A/ja
Publication of JP2011510974A5 publication Critical patent/JP2011510974A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2010544844A 2008-01-30 2009-01-30 ＨＭＧ−ＣｏＡ還元酵素阻害剤の調節放出製剤 Pending JP2011510974A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN145KO2008 2008-01-30
PCT/IN2009/000069 WO2009095934A1 (en) 2008-01-30 2009-01-30 Modified release formulations of hmg coa reductase inhibitors

Publications (2)

Publication Number Publication Date
JP2011510974A true JP2011510974A (ja) 2011-04-07
JP2011510974A5 JP2011510974A5 (https=) 2012-03-15

Family

ID=40638221

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010544844A Pending JP2011510974A (ja) 2008-01-30 2009-01-30 ＨＭＧ−ＣｏＡ還元酵素阻害剤の調節放出製剤

Country Status (8)

Country Link
US (1) US20110003837A1 (https=)
EP (1) EP2285353A1 (https=)
JP (1) JP2011510974A (https=)
AU (1) AU2009208610A1 (https=)
BR (1) BRPI0906728A2 (https=)
MX (1) MX2010008466A (https=)
WO (1) WO2009095934A1 (https=)
ZA (1) ZA201006157B (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11590161B2 (en) * 2018-08-13 2023-02-28 Viscera Labs, Inc. Therapeutic composition and methods

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007510714A (ja) * 2003-11-04 2007-04-26 アスファーマ・リミテッド 担体輸送スタチンの医薬製剤およびそれらの使用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6642268B2 (en) * 1994-09-13 2003-11-04 G.D. Searle & Co. Combination therapy employing ileal bile acid transport inhibiting benzothipines and HMG Co-A reductase inhibitors
IL149422A0 (en) * 1999-11-03 2002-11-10 Smith Howard J & Ass Pty Ltd Oral pharmaceutical compositions for liver therapy
GB0001621D0 (en) * 2000-01-26 2000-03-15 Astrazeneca Ab Pharmaceutical compositions
DE10209979A1 (de) * 2002-03-07 2003-09-25 Ratiopharm Gmbh Arzneimittel mit Cholesterolspiegel-senkenden Wirkstoffen mit zeitverzögerter Wirkstofffreisetzung
GB0217306D0 (en) * 2002-07-25 2002-09-04 Novartis Ag Compositions comprising organic compounds
US20050096391A1 (en) * 2003-10-10 2005-05-05 Per Holm Compositions comprising fenofibrate and rosuvastatin
US20050147620A1 (en) * 2004-01-05 2005-07-07 Karl Bozicevic Cinnamon formulation for reducing cholesterol and/or glucose levels
EP1968593B1 (en) * 2005-12-20 2017-08-23 LEK Pharmaceuticals d.d. Pharmaceutical composition comprising (e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl-(3r,5s)-3,5-dihydroxyhept-6-enoic acid

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007510714A (ja) * 2003-11-04 2007-04-26 アスファーマ・リミテッド 担体輸送スタチンの医薬製剤およびそれらの使用

Also Published As

Publication number Publication date
MX2010008466A (es) 2010-10-25
US20110003837A1 (en) 2011-01-06
AU2009208610A1 (en) 2009-08-06
BRPI0906728A2 (pt) 2015-07-07
WO2009095934A1 (en) 2009-08-06
EP2285353A1 (en) 2011-02-23
ZA201006157B (en) 2011-05-25

Similar Documents

Publication Publication Date Title
US20230414521A1 (en) Sustained-release formulations of colchicine and methods of using same
AU2007314795B2 (en) Controlled release complex composition comprising angiotensin-II-receptor blockers and HMG-CoA reductase inhibitors
US8394845B2 (en) Method of using combination preparation comprising angiotensin-II-receptor blocker and HMG-CoA reductase inhibitor
US9180101B2 (en) Pharmaceutical composition simultaneously having rapid-acting property and long-acting property
JP6976946B2 (ja) 生理活性の強い、ｕｒａｔ１のインヒビターを含む医薬組成物
TW201442742A (zh) 祛鐵斯若（ｄｅｆｅｒａｓｉｒｏｘ）之口服配方
CN109310642B (zh) 美沙拉嗪的口服药物组合物
TW201206501A (en) Pharmaceutical compositions comprising hydromorphone and naloxone
JP4457003B2 (ja) 放出制御医薬組成物
US20110052683A1 (en) Pharmaceutical preparation for treating cardiovascular disease
CN109152772B (zh) 烟酰胺的口服药物组合物
US20190008779A1 (en) Gemcabene compositions and methods of use thereof
US20110212175A1 (en) Combination preparation comprising angiotensin-ii-receptor blocker and hmg-coa reductase inhibitor
CN105431140B (zh) 含有缓释二甲双胍和速释HMG-CoA还原酶抑制剂的复合制剂
US20210361582A1 (en) Colchicine salicylate derivatives and methods of treatment
JP2011510974A (ja) ＨＭＧ−ＣｏＡ還元酵素阻害剤の調節放出製剤
JP7714473B2 (ja) ピリミジニルアミノピラゾール化合物の調節放出製剤および処置方法
KR102501636B1 (ko) 페노피브린산을 포함하는 경구용 정제 및 이의 제조방법
WO2014167439A1 (en) Modified release pharmaceutical compositions of topiramate or salts thereof

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120130

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20120130

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130910

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20131209

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20131216

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140107

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20140422